Reuters logo
BRIEF-Deciphera Pharma Initiates Late Stage Study In Gastrointestinal Cancer Patients
January 4, 2018 / 12:14 PM / in 12 days

BRIEF-Deciphera Pharma Initiates Late Stage Study In Gastrointestinal Cancer Patients

Jan 4 (Reuters) - Deciphera Pharmaceuticals Inc:

* DECIPHERA PHARMACEUTICALS INITIATES PHASE 3 CLINICAL STUDY WITH DCC-2618 IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (“INVICTUS” STUDY)

* DECIPHERA PHARMACEUTICALS - EXPECT TO REPORT TOP-LINE RESULTS IN 2019 AND, IF SUCCESSFUL, THE PHASE 3 STUDY COULD SERVE AS BASIS FOR NDS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below